Free US stock valuation multiples and PEG ratio analysis to identify reasonably priced growth companies. Our valuation framework helps you find stocks with the right balance of growth and value characteristics.
As of 2026-04-02, BioCryst Pharmaceuticals Inc. (BCRX) trades at a current price of $9.02, marking a 3.84% decline in recent trading sessions. This analysis examines key technical levels, prevailing market context for the biotech sector, and potential near-term scenarios for the stock, without making any investment recommendations. No recent earnings data is available for BCRX as of the current date, so market participants are largely relying on technical signals, sector trends, and potential up
What’s the outlook for BioCryst (BCRX) Stock this year | Price at $9.02, Down 3.84% - Insider Buying
BCRX - Stock Analysis
3377 Comments
537 Likes
1
Tyrec
Daily Reader
2 hours ago
Ah, too late for me. 😩
👍 224
Reply
2
Aleric
Power User
5 hours ago
This feels like a decision was made for me.
👍 105
Reply
3
Mckenzee
Consistent User
1 day ago
Positive intraday momentum may continue if volume sustains.
👍 218
Reply
4
Wakeen
Influential Reader
1 day ago
Very informative — breaks down complex topics clearly.
👍 262
Reply
5
Rithvi
Daily Reader
2 days ago
Real-time US stock market breadth indicators and technical analysis to gauge overall market health and direction. We provide comprehensive market timing tools that help you make better decisions about when to be aggressive or defensive.
👍 197
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.